Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.

Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L, Ghelli A, Moretti M, Betts CM, Martinelli GN, Ceroni AR, Curcio F, Carelli V, Rugolo M, Tallini G, Romeo G.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):9001-6. Epub 2007 May 15.

PMID:
17517629
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.

Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.

Dettori T, Frau DV, Lai ML, Mariotti S, Uccheddu A, Daniele GM, Tallini G, Faa G, Vanni R.

Genes Chromosomes Cancer. 2003 Sep;38(1):22-31.

PMID:
12874783
[PubMed - indexed for MEDLINE]
4.

Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.

Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M, Romeo G.

Cancer Res. 2006 Jun 15;66(12):6087-96.

PMID:
16778181
[PubMed - indexed for MEDLINE]
Free Article
5.

Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.

Máximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simões M.

Am J Pathol. 2002 May;160(5):1857-65.

PMID:
12000737
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.

Kurelac I, MacKay A, Lambros MB, Di Cesare E, Cenacchi G, Ceccarelli C, Morra I, Melcarne A, Morandi L, Calabrese FM, Attimonelli M, Tallini G, Reis-Filho JS, Gasparre G.

Hum Mol Genet. 2013 Jan 15;22(2):226-38. doi: 10.1093/hmg/dds422. Epub 2012 Oct 9.

PMID:
23049073
[PubMed - indexed for MEDLINE]
Free Article
7.

An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.

Gasparre G, Iommarini L, Porcelli AM, Lang M, Ferri GG, Kurelac I, Zuntini R, Mariani E, Pennisi LF, Pasquini E, Pasquinelli G, Ghelli A, Bonora E, Ceccarelli C, Rugolo M, Salfi N, Romeo G, Carelli V.

Hum Mutat. 2009 Mar;30(3):391-6. doi: 10.1002/humu.20870.

PMID:
19086058
[PubMed - indexed for MEDLINE]
8.

High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.

Abu-Amero KK, Alzahrani AS, Zou M, Shi Y.

Oncogene. 2005 Feb 17;24(8):1455-60.

PMID:
15608681
[PubMed - indexed for MEDLINE]
9.

Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.

Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD Jr, Mutter GL, Vijg J, Dahia PL, Eng C.

Oncogene. 2000 Apr 13;19(16):2060-6.

PMID:
10803467
[PubMed - indexed for MEDLINE]
Free Article
10.

Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference?

Tsybrovskyy O, Rössmann-Tsybrovskyy M.

Histopathology. 2009 Dec;55(6):665-82. doi: 10.1111/j.1365-2559.2009.03441.x.

PMID:
20002768
[PubMed - indexed for MEDLINE]
11.

Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.

Tallini G, Ladanyi M, Rosai J, Jhanwar SC.

Cytogenet Cell Genet. 1994;66(4):253-9.

PMID:
7909283
[PubMed - indexed for MEDLINE]
12.

Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Mete O, Asa SL.

Endocr Pathol. 2010 Mar;21(1):16-24. doi: 10.1007/s12022-009-9102-2. Review.

PMID:
20013317
[PubMed - indexed for MEDLINE]
13.

Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.

Corver WE, van Wezel T, Molenaar K, Schrumpf M, van den Akker B, van Eijk R, Ruano Neto D, Oosting J, Morreau H.

Genes Chromosomes Cancer. 2014 Oct;53(10):833-44. doi: 10.1002/gcc.22194. Epub 2014 Jun 7.

PMID:
24909752
[PubMed - in process]
14.

Oncocytic carcinoma of the breast: frequency, morphology and follow-up.

Ragazzi M, de Biase D, Betts CM, Farnedi A, Ramadan SS, Tallini G, Reis-Filho JS, Eusebi V.

Hum Pathol. 2011 Feb;42(2):166-75. doi: 10.1016/j.humpath.2010.07.014. Epub 2010 Nov 26.

PMID:
21111455
[PubMed - indexed for MEDLINE]
15.

Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.

Witte J, Lehmann S, Wulfert M, Yang Q, Röher HD.

World J Surg. 2007 Jan;31(1):51-9.

PMID:
17171498
[PubMed - indexed for MEDLINE]
16.

The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization.

Porcelli AM, Ghelli A, Ceccarelli C, Lang M, Cenacchi G, Capristo M, Pennisi LF, Morra I, Ciccarelli E, Melcarne A, Bartoletti-Stella A, Salfi N, Tallini G, Martinuzzi A, Carelli V, Attimonelli M, Rugolo M, Romeo G, Gasparre G.

Hum Mol Genet. 2010 Mar 15;19(6):1019-32. doi: 10.1093/hmg/ddp566. Epub 2009 Dec 22.

PMID:
20028790
[PubMed - indexed for MEDLINE]
Free Article
17.

Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.

Máximo V, Lima J, Soares P, Botelho T, Gomes L, Sobrinho-Simões M.

Mitochondrion. 2005 Oct;5(5):333-40.

PMID:
16183030
[PubMed - indexed for MEDLINE]
18.

Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.

Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW.

World J Surg. 2008 May;32(5):722-8. doi: 10.1007/s00268-007-9431-6.

PMID:
18235983
[PubMed - indexed for MEDLINE]
19.

How humans stand out in frontal lobe scaling.

Smaers JB.

Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):E3682. doi: 10.1073/pnas.1308850110. Epub 2013 Sep 12. No abstract available.

PMID:
24029020
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Molecular features of thyroid oncocytic tumors.

Gasparre G, Bonora E, Tallini G, Romeo G.

Mol Cell Endocrinol. 2010 May 28;321(1):67-76. doi: 10.1016/j.mce.2010.02.022. Epub 2010 Feb 23. Review.

PMID:
20184940
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk